Note that Goldman Sachs met with Megan Baldwin in Sydney after the recent US conference. Expect big things soon.
- Forums
- ASX - By Stock
- OPT
- Title moderated
Title moderated
-
-
Share
Who sees more upside than the $5.20 AUD target by GS?
OPT should be worth more than that to Regeneron or Genentech or ?
Especially if the DME trial turns out well.
- There are more pages in this discussion • 3 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.0¢ |
Change
0.030(4.76%) |
Mkt cap ! $812.5M |
Open | High | Low | Value | Volume |
62.0¢ | 67.5¢ | 62.0¢ | $2.533M | 3.887M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 14912 | 66.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 19820 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 14912 | 0.660 |
1 | 27404 | 0.655 |
4 | 82704 | 0.650 |
1 | 27404 | 0.645 |
3 | 58653 | 0.640 |
Price($) | Vol. | No. |
---|---|---|
0.670 | 19820 | 2 |
0.675 | 45076 | 3 |
0.680 | 78154 | 3 |
0.685 | 69430 | 2 |
0.690 | 36440 | 3 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |